This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →
MAEVE
GLENMARK PHARMACEUTICALS CANADA INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is MAEVE discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that MAEVE 0.35MG has been permanently discontinued (last updated October 27, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is MAEVE not available?
The reason the manufacturer reported: Business reasons.
Birth Control Pill Shortage in Canada: Min-Ovral, Seasonique & More
Which birth control pills and rings are in shortage in Canada right now — Min-Ovral, Seasonique, Seasonale, Aviane, Apri, Brevicon, Mya, Tri-Cira, Maeve, Haloette — and how to switch to a same-formula equivalent without a gap in protection.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
MOVISSE
SENADOR LABORATORIES PRIVATE LIMITED
JENCYCLA
LUPIN PHARMA CANADA LIMITED
Other Products
NORLUTATE
SEARCHLIGHT PHARMA INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-09-29
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02458683
Strength
0.35MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
NORETHINDRONE
Tier
Unrated
Last Updated
2026-09-29
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
MAEVE has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from GLENMARK PHARMACEUTICALS CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02466783
DIN 02462060
DIN 02421437
DIN 02421445
30MG · DIN 02518910
750MG · DIN 02528495
20MG · DIN 02544369
5MG · DIN 02519852
10MG · DIN 02519860
600MG · DIN 02410990
800MG · DIN 02411008
40MG · DIN 02469820